Oscine Therapeutics Oscine Therapeutics is a company developing a cell therapy platform for the treatment of CNS diseases. | Applied Biological Materials Applied Biological Materials is a company that provides research reagents. | ![]() Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics. | ![]() Caribou Biosciences Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company. | ||
Founding Date | Founding Date N/A | Founding Date 2020 | Founding Date 2004 | Founding Date 2013 | Founding Date 2012 |
Type | Type Private | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Rochester, US HQ | Locations Dallas, US HQ | Locations Richmond, CA HQ Richmond, CA Ferndale, US | Locations Cambridge, US HQ Boulder, US Cambridge, US | Locations Berkeley, US HQ |
Employees | Employees N/A | Employees 5220% decrease | Employees 635% increase | Employees 20816% increase | Employees 1477% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 385.3 m | Valuation ($) N/A | Valuation ($) 256.5 m | Valuation ($) 174.4 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $9.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $40.5m (FY, 2025) | Revenue (est.) $11.2m (FY, 2025) |
Net income | Net income N/A | Net income ($109m) (FY, 2025) | Net income N/A | Net income ($160.1m) (FY, 2025) | Net income ($148.1m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 125m | Total funding raised N/A | Total funding raised $ 210m | Total funding raised $ 159.5m |
Taysha Gene Therapies is a biotechnology company that develops therapies.
View companyApplied Biological Materials is a company that provides research reagents.
View company
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
View company
Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company.
View company